Jane Street
FTH icon

Jane Street’s Faeth Therapeutics FTH Stock Holding History

Jane Street’s Portfolio FTH Stock Details FTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$503K Buy
20,117
+11,245
+127% +$260K ﹤0.01% 8008
2026
Q1 		$280K Buy
+8,872
New +$177K ﹤0.01% 9376
2022
Q3 		– Sell
-696
Closed -$32K – 10412
2022
Q2 		$32K Buy
696
+158
+29% +$5.92K ﹤0.01% 9041
2022
Q1 		$25K Buy
+538
New +$42.8K ﹤0.01% 9883
2021
Q4 		– Sell
-539
Closed -$113K – 10771
2021
Q3 		$113K Buy
+539
New +$98.1K ﹤0.01% 9228

Other funds holding FTH

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Avoro Capital Advisors
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Fairmount Funds Management
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
Logos Global Management
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
RA Capital Management
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vivo Capital
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Caligan Partners
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
BGI
B Group Inc Dallas, Texas $213M AUM 96.05% 1-Year Est. Return

Jane Street's FTH Position: Q2 2026 in Review

Jane Street increased its Faeth Therapeutics (FTH) stake by 127% in Q2 2026, buying an estimated $260K and bringing the position to 20,117 shares worth $503K. The position accounts for ﹤0.01% of the portfolio, ranked #8008.

Jane Street first reported a position in FTH in Q3 2021 and has held it in 5 quarters since. 45 funds tracked by Wall St. Rank hold FTH as of Q2 2026.

  • Jane Street held 20,117 shares of Faeth Therapeutics worth $503K as of Q2 2026.
  • Jane Street bought 11,245 Faeth Therapeutics shares in Q2 2026, an estimated $260K.
  • Faeth Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #8008 holding.
  • Jane Street first reported a position in Faeth Therapeutics in Q3 2021 and has held it in 5 quarters since.
  • 45 funds tracked by Wall St. Rank held Faeth Therapeutics as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.